Literature DB >> 20518674

Observation of probable persistent, undetected Trichomonas vaginalis infection among HIV-positive women.

Megan Gatski, Patricia Kissinger.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20518674      PMCID： PMC2881477          DOI： 10.1086/653443

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  5 in total

1.  Persistent, undetected Trichomonas vaginalis infections?

Authors:  Thomas A Peterman; Lin H Tian; Carol A Metcalf; C Kevin Malotte; Sindy M Paul; John M Douglas
Journal:  Clin Infect Dis       Date:  2009-01-15       Impact factor: 9.079

2.  Trichomonas vaginalis and amplification of HIV-1 transmission.

Authors:  F Sorvillo; P Kerndt
Journal:  Lancet       Date:  1998-01-17       Impact factor: 79.321

3.  Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: results from a cohort study.

Authors:  M Laga; A Manoka; M Kivuvu; B Malele; M Tuliza; N Nzila; J Goeman; F Behets; V Batter; M Alary
Journal:  AIDS       Date:  1993-01       Impact factor: 4.177

4.  Infection with Trichomonas vaginalis increases the risk of HIV-1 acquisition.

Authors:  R Scott McClelland; Laura Sangare; Wisal M Hassan; Ludo Lavreys; Kishorchandra Mandaliya; James Kiarie; Jeckoniah Ndinya-Achola; Walter Jaoko; Jared M Baeten
Journal:  J Infect Dis       Date:  2007-01-22       Impact factor: 5.226

Review 5.  Trichomonas vaginalis, HIV, and African-Americans.

Authors:  F Sorvillo; L Smith; P Kerndt; L Ash
Journal:  Emerg Infect Dis       Date:  2001 Nov-Dec       Impact factor: 6.883
  5 in total
  14 in total

1.  The influence of bacterial vaginosis on the response to Trichomonas vaginalis treatment among HIV-infected women.

Authors:  Megan Gatski; David H Martin; Judy Levison; Leandro Mena; Rebecca A Clark; Mary Murphy; Harold Henderson; Norine Schmidt; Patricia Kissinger
Journal:  Sex Transm Infect       Date:  2011-01-29       Impact factor: 3.519

2.  Suboptimal Trichomonas vaginalis Antigen Test Performance in a Low-Prevalence Sexually Transmitted Infection Community.

Authors:  Kimber L Munson; Maureen Napierala; Erik Munson
Journal:  J Clin Microbiol       Date:  2015-12-09       Impact factor: 5.948

3.  A randomized treatment trial: single versus 7-day dose of metronidazole for the treatment of Trichomonas vaginalis among HIV-infected women.

Authors:  Patricia Kissinger; Leandro Mena; Judy Levison; Rebecca A Clark; Megan Gatski; Harold Henderson; Norine Schmidt; Susan L Rosenthal; Leann Myers; David H Martin
Journal:  J Acquir Immune Defic Syndr       Date:  2010-12-15       Impact factor: 3.731

4.  Sexually transmitted diseases treatment guidelines, 2015.

Authors:  Kimberly A Workowski; Gail A Bolan
Journal:  MMWR Recomm Rep       Date:  2015-06-05

Review 5.  Single-Dose Compared With Multidose Metronidazole for the Treatment of Trichomoniasis in Women: A Meta-Analysis.

Authors:  Katharine Howe; Patricia J Kissinger
Journal:  Sex Transm Dis       Date:  2017-01       Impact factor: 2.830

6.  Optimal Timing for Trichomonas vaginalis Test of Cure Using Nucleic Acid Amplification Testing.

Authors:  Megan Clare Craig-Kuhn; Charleigh Granade; Christina A Muzny; Barbara Van Der Pol; Rebecca Lillis; Stephanie N Taylor; Norine Schmidt; David H Martin; Patricia Kissinger
Journal:  Sex Transm Dis       Date:  2019-05       Impact factor: 2.830

7.  Clinical evidence for the role of Trichomonas vaginalis in regulation of secretory leukocyte protease inhibitor in the female genital tract.

Authors:  Jill S Huppert; Bin Huang; Chen Chen; Hassan Y Dawood; Raina N Fichorova
Journal:  J Infect Dis       Date:  2013-01-25       Impact factor: 5.226

8.  Comparative transcriptomic and proteomic analyses of Trichomonas vaginalis following adherence to fibronectin.

Authors:  Kuo-Yang Huang; Po-Jung Huang; Fu-Man Ku; Rose Lin; John F Alderete; Petrus Tang
Journal:  Infect Immun       Date:  2012-08-27       Impact factor: 3.441

9.  The influence of ART on the treatment of Trichomonas vaginalis among HIV-infected women.

Authors:  Alys Adamski; Rebecca A Clark; Leandro Mena; Harold Henderson; Judy Levison; Norine Schmidt; Hirut T Gebrekristos; David H Martin; Patricia Kissinger
Journal:  Clin Infect Dis       Date:  2014-06-09       Impact factor: 9.079

Review 10.  A Review of Evidence-Based Care of Symptomatic Trichomoniasis and Asymptomatic Trichomonas vaginalis Infections.

Authors:  Elissa Meites; Charlotte A Gaydos; Marcia M Hobbs; Patricia Kissinger; Paul Nyirjesy; Jane R Schwebke; W Evan Secor; Jack D Sobel; Kimberly A Workowski
Journal:  Clin Infect Dis       Date:  2015-12-15       Impact factor: 9.079
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.